Blood–brain barrier disruption
Osmotic blood brain barrier disruption Computerized tomographic monitoring of chemotherapeutic agent delivery
6
MR and cognitive testing of patients undergoing osmotic blood brain barrier disruption with intraarterial chemotherapy
16
Osmotic blood brain barrier disruption: CT and radionuclide imaging
10
Flat Detector Angio CT following Intra Arterial Therapy of Acute Ischemic Stroke: Identification of Hemorrhage and Distinction from Contrast Accumulation due to Blood Brain Barrier Disruption
6
Behavioral alterations following blood-brain barrier disruption stimulated by focused ultrasound
10
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption
10
Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy
12
Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats
32
Blood–brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation
9
Astrocyte derived VEGF A drives blood brain barrier disruption in CNS inflammatory disease
16
State-of-the-art of microbubble-assisted blood-brain barrier disruption
16
Blood Brain Barrier Disruption after Cardiac Surgery
6
Bacterial induction of Snail1 contributes to blood brain barrier disruption
12
Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion
12
The Application of MRI for Depiction of Subtle Blood Brain Barrier Disruption in Stroke
8
Hungerhuber, Edwin (2003): Neuroprotektion bei fokaler zerebraler Ischämie. Dissertation, LMU München: Medizinische Fakultät
133
Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption
12
Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood–brain barrier
11
Induction of VEGFA and Snail-1 by meningitic Escherichia coli mediates disruption of the blood-brain barrier
17
Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by Lipopolysaccharide
10